| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | XNSE Exchange | Y01476129 CUSIP |
| India Country | 175 Employees | 5 Aug 2026 Last Dividend | 15 Jul 2025 Last Split | - IPO Date |
Anuh Pharma Ltd. is a recognized entity in the pharmaceutical industry, primarily focused on the production and global distribution of Active Pharmaceutical Ingredients (APIs) and a variety of pharmaceutical formulations. As an essential contributor to the healthcare sector, the company plays a vital role in ensuring the availability of crucial medications by supplying these APIs for both the domestic market in India and the international markets. Anuh Pharma stands out for its commitment to producing high-quality products that adhere to international standards, making it a trusted partner in the pharmaceutical supply chain worldwide. The company’s strategic position in India, coupled with its extensive export activities, strengthens its global market presence and underscores its importance in facilitating access to critical healthcare solutions around the globe.
Anuh Pharma specializes in producing active pharmaceutical ingredients for anti-malarial drugs. These APIs are crucial for manufacturing medications that are pivotal in the fight against malaria, a life-threatening disease prevalent in many parts of the world. The company's expertise ensures that these key ingredients are available for the production of effective anti-malarial therapies, thereby supporting global health initiatives aimed at eradicating malaria.
Another area of specialization for Anuh Pharma is the production of APIs for macrolides, a class of antibiotics used to treat various bacterial infections. Macrolides are essential for combating a wide range of infectious diseases, making the company's role in supplying these APIs critical for public health. By providing high-quality macrolide APIs, Anuh Pharma contributes to the development of effective antibiotic treatments, addressing the ongoing challenge of bacterial resistance.
The company also produces APIs for corticosteroids, which are used in a wide array of pharmaceutical formulations for treating inflammation and other conditions such as asthma and autoimmune diseases. Corticosteroids play a significant role in managing inflammation and immune response, making these APIs vital for the development of treatments that improve the quality of life for individuals with chronic conditions. Anuh Pharma’s commitment to quality in the production of corticosteroid APIs ensures the availability of essential components for these therapeutic areas.